论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Wang T, Chen Y, Nie H, Huang Y, Zhao Y, Yang J
Received 5 May 2018
Accepted for publication 24 August 2018
Published 21 February 2019 Volume 2019:12 Pages 1447—1454
DOI https://doi.org/10.2147/OTT.S173207
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Ru Chen
Peer reviewer comments 3
Editor who approved publication: Dr William Cho
Introduction: Non-small-cell
lung cancer (NSCLC) accounts for more than half of all lung cancer cases.
Cytokines play an important role in NSCLC, including IL-27. IL-27 inhibits
NSCLC progression; however, the mechanism is not clear. The purpose of this
study is to investigate the effects of IL-27 on NSCLC cell proliferation and
metastasis.
Materials and methods: NSCLC
cells were treated with IL-27 or transfected with miR-935, and the cell
proliferation was assayed by Cell Counting Kit-8 (CCK-8) and colony formation.
Cell metastasis was analyzed by Transwell chamber system and wound healing
assay. IL-27 protein in the medium was analyzed by ELISA. IL-27 mRNA expression
was measured by quantitative reverse transcriptase-PCR.
Results: We found
that IL-27 played an inhibiting role in NSCLC cell proliferation and
metastasis. The molecular mechanism of the suppressing role of IL-27 in NSCLC
was regulated by miR-935. IL-27 expression was negatively associated with
miR-935 in the clinical NSCLC samples.
Conclusion: The study
revealed that IL-27 decreased lung cancer cell proliferation and metastasis via
miR-935.
Keywords: non-small
cell lung cancer, IL-27, miR-935
